I’ve added five new stocks in the model today, including newcomer Biogen. The company’s stock price fell sharply during the past few days after study data for Biogen’s multiple sclerosis treatment produced disappointing results. Consequently, many investors sold their Biogen shares, which created an excellent buying opportunity for us!
